ValuEngine Issues Buy Recommendation on Complete Genome

Emily Austin , Benzinga Staff Writer

July 27, 2011 6:14am Comments

ValuEngine issued a Buy recommendation on Complete Genome (NASDAQ: GNOM). On Tuesday, GNOM lost 6.64% of its value to finish the day at $13.21.

Posted-In: ValuEngine Initiation Analyst Ratings

Need analyst data?
Click here to see licensing options.

Stock	Firm	Action	PT
SEDG	B of A Securities	Maintains	411.0
PTLO	Piper Sandler	Maintains	28.0
AOUT	Lake Street	Maintains	26.0
RAPT	Piper Sandler	Maintains	52.0
OCX	Lake Street	Maintains	6.0

1	BMY, AAPL: Dow Falls Over 150 Points After Powell's Comments On Rate Cuts: In...
2	UUP: Trump's Inflation Honeymoon Is Over—And Powell's Patienc...
3	$BTC, $DOGE: Bitcoin, Ethereum, Dogecoin Slide As Hotter-Than-Expected...
4	PI, WING: Stock Market Today: S&P 500, Nasdaq To Open H...
5	VOO, GLD: Fed Skips Rate Cut Again—But Reveals So...
6	AAPL: Apple Q3 Earnings: Revenue, EPS Smash...
7	QS, JOBY: The 5 Most Volatile Stocks Th...

1	INTC: Intel Exec Exodus As CEO Lip-Bu Tan Slashes Workforce, Delays Ohio Chip Plan...
2	MSTR: Strategy Stock Climbs 1.9% After Key Trading Signal
3	AAPL, HOOD: HOOD Stock Falls Over 5% In Friday Pre-Market: What's Goi...
4	AAPL, COIN: Stock Market Today: Futures Drop On 'Aug 1'...
5	GELYF, VLKAF: BYD, Xpeng Lead Chinese EV Surge In Euro...
6	Peter Thiel-Backed Tacora Raises $685 Mi...
7	$ETH, $BTC: Profitable Whale Bets Big With...

Market Overview